Tools for comprehensive evaluation of sexual function in patients with multiple sclerosis.

Autor:	Gaviria Carrillo M; Neurología, Fundación Cardio Infantil Instituto de Cardiología, Universidad del Rosario, Bogotá, Colombia. Electronic address: marigaviria8@hotmail.com., Ortiz Salas PA; Neurología y Epidemiología, Fundación Cardio Infantil Instituto de Cardiología, Bogotá, Colombia., Rueda Vergara KP; Neurología, Universidad del Rosario, Bogotá, Colombia., Cortes Bernal GA; Neurología, Universidad del Rosario, Bogotá, Colombia., Nava Mesa M; Grupo de investigación en Neurociencias (NEUROS), Universidad del Rosario, Bogotá, Colombia., Moreno Medina K; Epidemiología, Fundación Cardio Infantil Instituto de Cardiología, Bogotá, Colombia.
Jazyk:	English; Spanish; Castilian
Zdroj:	Neurologia [Neurologia (Engl Ed)] 2020 Sep 08. Date of Electronic Publication: 2020 Sep 08.
DOI:	10.1016/j.nrl.2020.04.028
Abstrakt:	Introduction: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) that affects young adults, causing a variety of symptoms (motor alterations, visual alterations, loss of sphincter control, gait alterations) that impair the patient's functional status. However, other symptoms, such as sexual dysfunction, can also have an effect on quality of life. Development: Sexual dysfunction can occur at any time during the course of the disease; its prevalence varies between 50% and 90%, and it can be secondary to demyelinating lesions in the spinal cord and/or brain or caused by symptoms that do not directly involve the nervous system (fatigue; psychological, social, and cultural factors; etc.). Although its prevalence and impact on quality of life are well known, sexual dysfunction is still frequently underestimated. Therefore, in this article we review the different scales for assessing presence or severity of sexual dysfunction, in order to offer early multidisciplinary management. Conclusion: We evaluated 5 questionnaires that could identify the presence of sexual dysfunction in patients with MS and determine its aetiology, assisting in treatment decision making. MS must be understood as a complex disease that encompasses and compromises different aspects of patients' health, and goes beyond simply measuring disability. (Copyright © 2020 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu